Uttar Pradesh's Project Praveen is revolutionizing school education by integrating vocational training for students in ...

Innovative Initiative by a Young Student Sarthak Siddhant, a Class 12 student from JVM Shyamali School in Ranchi, has taken a ...

The Supreme Court on Monday directed the Central Board of Secondary Education (CBSE) to take all necessary steps to declare the Class 12 Improvement Examination results as soon as possible. The court ...

Prometheus Inc., an artificial intelligence startup co-led by Amazon.com Inc. founder Jeff Bezos, has raised $12 billion in funding. Axios reported today that the Series B round values the company at ...

Prime Minister Narendra Modi has completed 12 years at the helm of the Indian government, marking a political journey that has reshaped the country's electoral and governance landscape. From his first ...

The Post-Result Activities Portal for Class 12 answer script re-evaluation and marks verification is scheduled to open today, June 1. Students must apply online via ...

The Newport News shipyard is likely the final assembler of the proposed Trump-class battleship, a Navy official said. Jason Potter, performing the duties of assistant secretary of the Navy for ...

The Federal Government spent only N3.10tn on capital projects in the first nine months of 2025 despite accessing N11.89tn from various debt financing sources during the period, highlighting the wide ...

Ankyra Therapeutics, a clinical-stage biotechnology company pioneering anchored immunotherapy to deliver better outcomes for people with cancer and other serious diseases, announced two poster ...

Two southwest Michigan residents have filed what their attorneys are calling the first class-action lawsuit in the country over noise from a data center, alleging a Dowagiac facility has created a ...

WAYZATA, Minn. — Highway 12 will be closed in both directions between Central Avenue in Wayzata and Interstate 494 in Minnetonka starting Friday night as part of a two-weekend project to resurface the ...

Leukogene Therapeutics, Inc., an early‑stage oncology company developing MHC class II-engager immunotherapies for immunologically cold cancers, today announced two poster presentations at the American ...